Lactoperoxidase (LPO E.C. 1.11.1.7) is a glycoprotein belonging to the class of oxidoreductases and constitutes a notable member of the peroxidase enzyme family. The biological significance of LPO is attributed to its role as a natural defense system against microbial infection. In the current study, to examine the inhibitory effects of 8 different polyfluoro-substituted pyrazoline-type primary sulfonamide derivative compounds on LPO enzyme activity, LPO enzyme was extracted from buffalo milk and purified using affinity gel, resulting in a 2212.45-fold purification, a 19.31 % yield, and a specific activity of 4955.9 EU/mg. Ki values for the active inhibitors were determined to be between 1.02±0.53-6.67±2.94 µM, while their IC50 values were in the range of 0.144±0.03-0.798±0.07 µM. The IC50 value and Ki values for the most effective inhibitor, Compound 3, were calculated as 0.144±0.03 and 6.06±4.06 µM, respectively, and it was found that this compound inhibited LPO enzyme activity non-competitively.
Pharmacogenetics of Antidepressants: Overview of Dosing Strategies in Major Depressive Disorder Saja SAİD Gül ÖZBEY Therapeutic Use of Cannabinoids: Clinical Overview and Recent Updates Beril ALTUN The Xanthine Oxidase Inhibitory Activities of Natural-Based Compounds Targeting Gout Nurcan DEDEOĞLU The Relationship of Dementia and Diabetes Mehtap TUGRAK SAKARYA Rational Use of Drugs Dilan ÖZMEN ÖZGÜN Endocrine Therapy in Breast Cancer: Recent Advances in the Drugs Used Dilek AKSOY Strategies to Increase Solubility and Bioavailability of Drugs İrem ÇİNAR Emrah ÖZAKAR Rukiye SEVİNÇ ÖZAKAR Vesıcular Drug Delivery Systems Muhammet Enes ÖZMUTLU Rukiye SEVİNÇ ÖZAKAR Emrah ÖZAKAR Definition of Pharmacovigilance and Its Historical Development in the World and Türkiye Berna ÖZTÜRK KARAGÖZ